524768 — Emmessar Biotech and Nutrition Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹123.60m
- IN₹47.81m
- IN₹3.71m
Annual cashflow statement for Emmessar Biotech and Nutrition, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9.31 | 9.67 | 8.13 | 9.58 | 5.8 |
| Depreciation | |||||
| Non-Cash Items | -2.19 | -2.48 | -5.22 | -4.71 | -4.24 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.7 | -4.36 | 2.56 | -3.61 | 0.091 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 22.7 | 3.76 | 6.45 | 2.24 | 2.65 |
| Capital Expenditures | -3.06 | -0.263 | 0 | 0 | -0.085 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -23.1 | -5.2 | -6.43 | -2.3 | -2.48 |
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26.1 | -5.46 | -6.43 | -2.3 | -2.57 |
| Financing Cash Flow Items | — | — | — | 0.035 | 0.142 |
| Other Financing Cash Flow | |||||
| Cash from Financing Activities | — | — | — | 0.035 | 0.142 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.45 | -1.7 | 0.01 | -0.025 | 0.229 |